Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HalfLytely and Bisacodyl is a combination bowel preparation kit used primarily for cleansing the colon prior to colonoscopy in adults. The kit contains two main components: - Polyethylene glycol 3350 (PEG-3350) with electrolytes (sodium chloride, sodium bicarbonate, potassium chloride), which acts as an osmotic laxative by retaining water in the gastrointestinal tract to induce watery diarrhea. - Bisacodyl delayed-release tablets, a stimulant laxative that is hydrolyzed by intestinal enzymes and colonic bacteria into its active metabolite [bis-(p-hydroxyphenyl) pyridyl-2 methane; BHPM], which stimulates colonic peristalsis by acting directly on the colonic mucosa. The combined action of these agents results in effective bowel cleansing through both increased water retention (osmotic effect) and enhanced intestinal motility (stimulant effect). The product is administered orally as part of a split-dose regimen before procedures requiring clear visualization of the colon[1][2][3][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HalfLytely and Bisacodyl.